- ►aspetjournals.org AS Narang, RI Mahato - Pharmacological reviews, 2006 - ASPET Islet transplantation may be used to treat type I diabetes. Despite tremendous
progress in islet isolation, culture, and preservation, the clinical use of this
modality of treatment is limited due to post-transplantation challenges to ... Cited by 32 - Related articles - BL Direct - All 13 versions
PC Nett, HW Sollinger, T Alam - American Journal of Transplantation, 2003 - interscience.wiley.com Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease resulting in
destruction of the pancreatic β-cells in the islets of Langerhans. Commonly
employed treatment of IDDM requires periodic insulin therapy, which is not ... Cited by 12 - Related articles - BL Direct - All 3 versions
- ►ualberta.ca [PDF] RG Bretzel, H Jahr, M Eckhard, I Martin, D … - Langenbeck's Archives of Surgery, 2007 - Springer Abstract Introduction Long-term studies strongly suggest that tight control of
blood glucose can prevent the development and retard the progression of chronic
complications of type 1 diabetes mellitus. In contrast to conventional ... Cited by 12 - Related articles - BL Direct - All 5 versions
- ►shouxi.net A Mas, J Montané, XM Anguela, S Muñoz, AM … - Diabetes, 2006 - Am Diabetes Assoc Type 1 diabetic patients develop severe secondary complications because insulin
treatment does not guarantee normoglycemia. Thus, efficient regulation of
glucose homeostasis is a major challenge in diabetes therapy. Skeletal ... Cited by 10 - Related articles - BL Direct - All 6 versions
BRGEM Brendel - Panminerva medica, 2004 - 万方数据资源系统 Long-term studies strongly suggest that tight control of blood glucose can
prevent the development and retard the progression of chronic complications of
type 1 diabetes mellitus. In contrast to conventional insulin treatment, ... Cited by 23 - Related articles - BL Direct - All 5 versions
Y Cao, L Lam - Drugs Today, 2002 - journals.prous.com The evolution of insulin treatment of diabetes has dramatically changed the
natural course of this disease. Modern recombinant DNA technology has brought
about many new insulin analogues with improved pharmacokinetics, resulting ... Cited by 8 - Related articles - All 5 versions
- ►pdf.com.ru [PDF] IM Shaikh, KR Jadhav, S Ganga, VJ Kadam, … - Current Pharmaceutical Biotechnology, 2005 - ingentaconnect.com Abstract: Diabetes is a syndrome of disordered metabolism and inappropriate
hyperglycemia resulting from a deficiency of insulin secretion or insulin
resistance. Insulin, a pancreatic hormone, helps to lower the blood sugar ... Cited by 8 - Related articles - BL Direct - All 3 versions
- ►umich.edu [PDF] P Lei, A Ogunade, KL Kirkwood, SG Laychock … - Tissue engineering, 2007 - liebertonline.com Page 1. Efficient Production of Bioactive Insulin from Human Epidermal
Keratinocytes and Tissue-Engineered Skin Substitutes: Implications ... Cited by 6 - Related articles - BL Direct - All 6 versions
[CITATION] Pancreatic islet and stem cell transplantation in diabetes mellitus: results and perspectives
ML Hribal, F Tornei, A Pujol, R Menghini, D … - Journal of Cellular and Molecular Medicine, 2008 - interscience.wiley.com Molecular scanning of human insulin receptor substrate (Irs) genes revealed a
single lrs1 prevalent variant, a glycine to arginine change at codon 972
(G972R); previous in vitro studies had demonstrated that the presence of ... Cited by 2 - Related articles - All 2 versions
